BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36104936)

  • 1. Measuring population-level cure patterns for cancer patients in the United States.
    Xia C; Yu XQ; Chen W
    Int J Cancer; 2023 Feb; 152(4):738-748. PubMed ID: 36104936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Trends in Population-Level Cure of Cancer: The Australian Context.
    Kou K; Dasgupta P; Cramb SM; Yu XQ; Baade PD
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):625-635. PubMed ID: 31932416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
    AIRTUM Working Group
    Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative survival and cure fraction of gastric cancer estimated through flexible parametric models using data from population-based cancer registration during 2003-2012 in Linzhou, China.
    Chen Q; Liu SZ; Zhang SK; Cao XQ; Li BY; Quan PL; Guo LW; Dong L; Sun XB; Zhang Y; Zhang JG
    Cancer Med; 2020 Mar; 9(6):2243-2251. PubMed ID: 31994324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
    Stedman MR; Feuer EJ; Mariotto AB
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based survival-cure analysis of ER-negative breast cancer.
    Huang L; Johnson KA; Mariotto AB; Dignam JJ; Feuer EJ
    Breast Cancer Res Treat; 2010 Aug; 123(1):257-64. PubMed ID: 20130982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for Cure by Stage across the Cancer Spectrum in the United States.
    Hubbell E; Clarke CA; Smedby KE; Adami HO; Chang ET
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):206-214. PubMed ID: 38019271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilities of death from breast cancer and other causes among female breast cancer patients.
    Schairer C; Mink PJ; Carroll L; Devesa SS
    J Natl Cancer Inst; 2004 Sep; 96(17):1311-21. PubMed ID: 15339969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
    Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models.
    Andersson TM; Dickman PW; Eloranta S; Lambert PC
    BMC Med Res Methodol; 2011 Jun; 11():96. PubMed ID: 21696598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of age and tumour stage in the temporal pattern of 'cure' from stomach cancer: a population-based study in Osaka, Japan.
    Ito Y; Nakayama T; Tsukuma H; Miyashiro I; Ioka A; Sugimoto T; Rachet B
    Cancer Epidemiol; 2012 Apr; 36(2):128-32. PubMed ID: 22300953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chances of hepatic resection curing hepatocellular carcinoma.
    Cucchetti A; Zhong J; Berhane S; Toyoda H; Shi K; Tada T; Chong CCN; Xiang BD; Li LQ; Lai PBS; Ercolani G; Mazzaferro V; Kudo M; Cescon M; Pinna AD; Kumada T; Johnson PJ
    J Hepatol; 2020 Apr; 72(4):711-717. PubMed ID: 31790765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after childhood acute lymphoblastic leukaemia: population-based trends in cure and relapse by clinical characteristics.
    Smith L; Glaser AW; Kinsey SE; Greenwood DC; Chilton L; Moorman AV; Feltbower RG
    Br J Haematol; 2018 Sep; 182(6):851-858. PubMed ID: 29808915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to estimate time-to-cure from cancer registries data.
    Boussari O; Romain G; Remontet L; Bossard N; Mounier M; Bouvier AM; Binquet C; Colonna M; Jooste V
    Cancer Epidemiol; 2018 Apr; 53():72-80. PubMed ID: 29414635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis.
    Dubecz A; Gall I; Solymosi N; Schweigert M; Peters JH; Feith M; Stein HJ
    J Thorac Oncol; 2012 Feb; 7(2):443-7. PubMed ID: 22173700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of older breast cancer patients: population-based estimates over three decades.
    Kanapuru B; Ershler WB; Hesdorffer C; Jemal A; Yates JW
    Breast Cancer Res Treat; 2012 Jul; 134(2):853-7. PubMed ID: 22710707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The improved cure fraction for esophageal cancer in Linzhou city.
    Liu S; Guo L; Chen Q; Yu L; Li B; Cao X; Sun X
    BMC Cancer; 2018 Oct; 18(1):949. PubMed ID: 30285671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.